Expansion of use for two assays gives patients the option to self-collect specimens at home and in the clinic, which may help address gaps in screening
With the global cancer burden growing, is a universal germline genomic testing approach the key to more effectively combating the disease?
Recent advances in pharmacogenomic testing—and their role in ensuring safe, effective treatment selection for precision oncology
When it comes to cancer, patients’ greatest fear is diagnostic delays—and they believe digital pathology and AI can reduce those delays
The company is hiring at least 100 sales representatives this year to spread awareness and uptake of its recently FDA-approved Shield test